ArticleFrontiers in pharmacology2024

Re-challenging pralsetinib following recovery from pneumocystis jirovecii pneumonia in a lung cancer patient: a Case Report.

Zhe Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.